Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Manufacturing	4.42B	5.66B	4.80B	3.81B	3.97B
Pharmaceutical Distribution Industry	5.09B	4.08B	4.20B	4.06B	3.15B
Cosmetics Manufacturing	660.09M	752.07M	706.76M	634.30M	841.35M
Other	243.99M	256.78M	322.95M	168.63M	44.89M
Unallocated Other	-	31.87M	22.31M	19.52M	17.29M
Offset of Business Segment	-1.41B	-	-	-	-
Total	9.00B	10.79B	10.06B	8.69B	8.02B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	8.59B	10.36B	9.60B	8.29B	7.65B
Overseas	415.06M	424.48M	457.64M	401.61M	371.91M
Total	9.00B	10.79B	10.06B	8.69B	8.02B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error